Acro Biomedical (ACBM) Change in Account Payables (2015 - 2021)

Acro Biomedical's Change in Account Payables history runs 5 years deep, the most recent figure standing at $10125.0 for Q4 2021.

• In Q4 2021, Change in Account Payables changed N/A year-over-year to $10125.0; the TTM figure through Dec 2021 stood at $13095.0 (changed N/A YoY), while the FY2022 annual figure was $50374.0, up 3343.2% from the prior year.
• Change in Account Payables was $10125.0 for Q4 2021 at Acro Biomedical, up from $4000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $10125.0 in Q4 2021 to a low of -$5030.0 in Q1 2017.
• Historically, Change in Account Payables has averaged $3273.8 across 3 years, with a median of $4000.0 in 2020.
• The sharpest annual moves came in 2017 and 2021: Change in Account Payables tumbled 407.65% in 2017, then changed 0.0% in 2021.
• A 3-year view of Change in Account Payables shows it stood at -$5030.0 in 2017, then soared by 179.52% to $4000.0 in 2020, then soared by 153.12% to $10125.0 in 2021.
• The last three Change in Account Payables figures came in at $10125.0 (Q4 2021), $4000.0 (Q3 2021), and $4000.0 (Q3 2020), per Business Quant data.